학술논문
Anti-Inflammatory Treatment of COVID-19 Pneumonia With Tofacitinib Alone or in Combination With Dexamethasone is Safe and Possibly Superior to Dexamethasone as a Single Agent in a Predominantly African American Cohort
Document Type
Article
Author
Source
In Mayo Clinic Proceedings: Innovations, Quality & Outcomes June 2021 5(3):605-613
Subject
Language
ISSN
2542-4548